• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视胰腺神经内分泌肿瘤的临床病理预后因素以更好地确定不良预后

Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis.

作者信息

Aysal Anil, Agalar Cihan, Egeli Tufan, Unek Tarkan, Oztop Ilhan, Obuz Funda, Sagol Ozgul

机构信息

Department of Pathology, Dokuz Eylul University School of Medicine, Izmir, Turkey.

Department of General Surgery, Dokuz Eylul University School of Medicine, Izmir, Turkey.

出版信息

Endocr Pathol. 2021 Dec;32(4):461-472. doi: 10.1007/s12022-021-09687-w. Epub 2021 Jul 20.

DOI:10.1007/s12022-021-09687-w
PMID:34283399
Abstract

The question of how successful we are in predicting pancreatic neuroendocrine tumors (panNET) with poor prognosis has not been fully answered yet. The aim of this study was to investigate the effects of clinicopathological features on prognosis and to determine their validity in prediction of prognosis and whether a better prognostic classification can be made. Fifty-six patients who underwent pancreatic resection for pancreatic neuroendocrine tumor were included. The associations between clinicopathological parameters and prognosis were evaluated statistically. Efficiencies of different thresholds for tumor size, mitotic count, and Ki67 proliferation index for prognosis prediction were compared. Vascular invasion was statistically associated with high tumor grade, advanced pT stage, and mortality rate. The presence of non-functional tumor, lymphatic invasion, and > 10 cm tumor size were significantly related to shorter overall survival. Advanced pT stage (pT3-4), > 5 cm tumor size, and high tumor grade (grades 2-3) were significantly associated with shorter disease-free survival. The mortality rate showed the strongest statistical significance with mitotic count when grouped as 1: < 2, 2: 2-10, and 3: > 10 mitosis/ 2 mm. The 10% threshold value for Ki67 index was more successful in predicting adverse prognosis. Among the morphologic variants, the ductulo-insular variant was the most promising to have positive prognostic value in our series, although no statistical significance was detected. In conclusion, threshold values of 5 cm and 10 cm for tumor size, 10% for Ki67 proliferation index, and 10/2 mm for mitotic count and vascular and lymphatic invasion assessed separately are potential prognostic candidates for better stratification of panNETs.

摘要

我们在预测预后不良的胰腺神经内分泌肿瘤(panNET)方面的成功程度问题尚未得到充分解答。本研究的目的是调查临床病理特征对预后的影响,并确定其在预后预测中的有效性,以及是否可以进行更好的预后分类。纳入了56例因胰腺神经内分泌肿瘤接受胰腺切除术的患者。对临床病理参数与预后之间的关联进行了统计学评估。比较了肿瘤大小、有丝分裂计数和Ki67增殖指数的不同阈值对预后预测的效率。血管侵犯与高肿瘤分级、晚期pT分期和死亡率在统计学上相关。无功能肿瘤的存在、淋巴管侵犯和肿瘤大小>10 cm与较短的总生存期显著相关。晚期pT分期(pT3-4)、肿瘤大小>5 cm和高肿瘤分级(2-3级)与较短的无病生存期显著相关。当按1:<2、2:2-10和3:>10个有丝分裂/2 mm分组时,死亡率与有丝分裂计数显示出最强的统计学意义。Ki67指数的10%阈值在预测不良预后方面更成功。在形态学变异中,导管岛状变异在我们的系列中最有希望具有阳性预后价值,尽管未检测到统计学意义。总之,肿瘤大小的5 cm和10 cm阈值、Ki67增殖指数的10%、有丝分裂计数的10/2 mm以及分别评估的血管和淋巴管侵犯是panNETs更好分层的潜在预后指标。

相似文献

1
Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis.重新审视胰腺神经内分泌肿瘤的临床病理预后因素以更好地确定不良预后
Endocr Pathol. 2021 Dec;32(4):461-472. doi: 10.1007/s12022-021-09687-w. Epub 2021 Jul 20.
2
Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification.胰腺神经内分泌肿瘤的形态学变异:临床病理分析和预后分层。
Endocr Pathol. 2020 Sep;31(3):239-253. doi: 10.1007/s12022-020-09628-z.
3
Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.Ki67 增殖指数和有丝分裂率的纳入可提高分化良好的胰腺神经内分泌肿瘤的分级。
Am J Surg Pathol. 2013 Nov;37(11):1671-7. doi: 10.1097/PAS.0000000000000089.
4
The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.磷酸化组蛋白H3辅助有丝分裂计数和Ki67评分在高分化胰腺神经内分泌肿瘤的肿瘤分级判定及远处转移预测中的作用
Endocr Pathol. 2016 Jun;27(2):162-70. doi: 10.1007/s12022-016-9424-9.
5
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别(世界卫生组织G3级)胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性,包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.
6
Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.循环肿瘤细胞对胰腺和中肠神经内分泌肿瘤患者预后的预测价值。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):872-882. doi: 10.1210/clinem/dgaa822.
7
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties.原发性和转移部位胃肠胰神经内分泌肿瘤的预后特征:分级、肠系膜肿瘤沉积物及新出现的特点。
J Neuroendocrinol. 2021 Aug;33(8):e13000. doi: 10.1111/jne.13000. Epub 2021 Jul 16.
8
Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.基于新分级分类法的高分化胰腺神经内分泌肿瘤根治性切除术后复发危险因素分析
J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):418-25. doi: 10.1002/jhbp.47. Epub 2013 Oct 20.
9
High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors.高级别进展预示胰腺神经内分泌肿瘤不良预后。
Neuroendocrinology. 2020;110(11-12):891-898. doi: 10.1159/000504392. Epub 2019 Oct 29.
10
Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival.碳酸酐酶 9 在分化良好的胰腺神经内分泌肿瘤中的表达可能与侵袭性行为和不良预后相关。
Virchows Arch. 2018 May;472(5):739-748. doi: 10.1007/s00428-018-2353-x. Epub 2018 Apr 18.

引用本文的文献

1
Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-Up.手术切除的高分化胰腺神经内分泌肿瘤的预后特征:对904例患者进行7882人年随访的分析
Endocr Pathol. 2025 Jun 27;36(1):24. doi: 10.1007/s12022-025-09866-z.
2
Well-Differentiated Jejunoileal Neuroendocrine Tumors and Corresponding Liver Metastases: Mesenteric Fibrogenesis and Extramural Vascular Invasion in Tumor Progression.高分化空回肠神经内分泌肿瘤及其相应的肝转移灶:肿瘤进展中的肠系膜纤维生成和壁外血管侵犯
Cancers (Basel). 2025 Apr 28;17(9):1486. doi: 10.3390/cancers17091486.
3

本文引用的文献

1
Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification.胰腺神经内分泌肿瘤的形态学变异:临床病理分析和预后分层。
Endocr Pathol. 2020 Sep;31(3):239-253. doi: 10.1007/s12022-020-09628-z.
2
Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.胰腺神经内分泌肿瘤的总生存和手术结局的预后和预测因素:最新进展和争议。
Expert Rev Anticancer Ther. 2019 Dec;19(12):1029-1050. doi: 10.1080/14737140.2019.1693893. Epub 2019 Nov 27.
3
A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification.
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.
G2 胰腺神经内分泌肿瘤的次分级为 2A(Ki67 为 3%至<10%)与 2B(10%至≤20%),可识别出符合不断发展的管理方案的行为上明显不同的亚组。
Ann Surg Oncol. 2024 Oct;31(10):7001-7011. doi: 10.1245/s10434-024-15632-y. Epub 2024 Jul 2.
4
Pancreatic Neuroendocrine Microtumors (WHO 2022) Are Not Always Low-Grade Neoplasms: A Case with a Highly Increased Proliferation Rate.胰腺神经内分泌微瘤(2022年世界卫生组织分类)并非总是低级别肿瘤:一例增殖率显著升高的病例
Endocr Pathol. 2024 Jun;35(2):147-153. doi: 10.1007/s12022-024-09802-7. Epub 2024 Feb 26.
5
A Machine Learning Approach Using [F]FDG PET-Based Radiomics for Prediction of Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumor.一种基于[F]FDG PET的放射组学的机器学习方法用于预测胰腺神经内分泌肿瘤的肿瘤分级和预后
Mol Imaging Biol. 2023 Oct;25(5):897-910. doi: 10.1007/s11307-023-01832-7. Epub 2023 Jul 3.
6
Risk Stratification of Pancreatic Neuroendocrine Neoplasms Based on Clinical, Pathological, and Molecular Characteristics.基于临床、病理和分子特征的胰腺神经内分泌肿瘤风险分层
J Clin Med. 2022 Dec 15;11(24):7456. doi: 10.3390/jcm11247456.
7
A New Preoperative Scoring System for Predicting Aggressiveness of Non-Functioning Pancreatic Neuroendocrine Neoplasms.一种用于预测无功能性胰腺神经内分泌肿瘤侵袭性的新型术前评分系统。
Diagnostics (Basel). 2022 Feb 3;12(2):397. doi: 10.3390/diagnostics12020397.
《以新的世界卫生组织分类为重点的胰腺神经内分泌肿瘤的临床病理和分子学更新》
Arch Pathol Lab Med. 2019 Nov;143(11):1317-1326. doi: 10.5858/arpa.2019-0338-RA. Epub 2019 Sep 11.
4
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age.分化良好的胰腺神经内分泌肿瘤的大小与 Ki67 增殖指数相关,与年龄无关。
Dig Liver Dis. 2019 May;51(5):735-740. doi: 10.1016/j.dld.2019.01.008. Epub 2019 Jan 22.
5
Can we predict recurrence in WHO G1-G2 pancreatic neuroendocrine neoplasms? Results from a multi-institutional Spanish study.我们能否预测 WHO G1-G2 胰腺神经内分泌肿瘤的复发?一项多机构西班牙研究的结果。
Pancreatology. 2019 Mar;19(2):367-371. doi: 10.1016/j.pan.2019.01.007. Epub 2019 Jan 19.
6
Life expectancy in pancreatic neuroendocrine cancer.胰腺神经内分泌肿瘤的预期寿命。
Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):88-97. doi: 10.1016/j.clinre.2018.08.005. Epub 2018 Sep 13.
7
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.Ki67 预测胰腺神经内分泌肿瘤的复发和生存。
Ann Surg Oncol. 2018 Aug;25(8):2467-2474. doi: 10.1245/s10434-018-6518-2. Epub 2018 May 22.
8
Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates.胃肠胰神经内分泌肿瘤:精选病理学回顾与分子更新。
Histopathology. 2018 Jan;72(1):153-167. doi: 10.1111/his.13367.
9
Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.血管生成和肿瘤大小是影响胰腺神经内分泌瘤切除术后复发的重要预测因素。
Ann Surg Oncol. 2017 Aug;24(8):2363-2370. doi: 10.1245/s10434-017-5823-5. Epub 2017 Mar 7.
10
The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.磷酸化组蛋白H3辅助有丝分裂计数和Ki67评分在高分化胰腺神经内分泌肿瘤的肿瘤分级判定及远处转移预测中的作用
Endocr Pathol. 2016 Jun;27(2):162-70. doi: 10.1007/s12022-016-9424-9.